Abstract
Background Initial emergency department (ED) assessment can use early warning scores to identify and prioritise patients who need time-critical treatment. We aimed to determine the accuracy of the National Early Warning Score version 2 (NEWS2) for predicting the need for time-critical treatment.
Methods We undertook a single centre retrospective observational cohort study. We randomly selected 4000 adults who attended a tertiary hospital ED in 2022 and had NEWS2 routinely recorded on electronic patient records. The first NEWS2 score and vital signs were extracted from electronic records. Research nurses selected cases that received a potentially time-critical treatment. Two independent clinical experts then determined whether time-critical treatment was or should have been received, using an expert consensus derived list of interventions. We used receiver operating characteristic (ROC) analysis and calculated sensitivity and specified at pre-defined thresholds to evaluate the accuracy of NEWS2 for predicting need for time-critical intervention.
Results After excluding ten patients who received their intervention before NEWS2 recording, 164/3990 (4.1%) needed time-critical treatment and 71/3990 (1.8%) died within seven days. NEWS2 predicted need for time-critical treatment with a c-statistic of 0.807 (95% confidence interval 0.765 to 0.849) and death within seven days with a c-statistic of 0.865 (0.813, 0.917). NEWS2>4 predicted need for time-critical treatment with sensitivity of 0.518 (0.442, 0.593) and positive predictive value of 0.258 (0.213, 0.307). Patients needing emergency surgery, antibiotics for open fractures, insulin infusion, or manipulation of limb-threatening injuries frequently had NEWS2≤4. Patients with NEWS2>4 who did not need time-critical treatment frequently scored three points on NEWS2 for their respiratory rate, conscious level, or receiving supplemental oxygen.
Conclusion NEWS2 has modest accuracy for predicting need for time-critical treatment. We have identified time-critical interventions that frequently have low NEWS2 scores and NEWS2 parameters than may overestimate need for time-critical intervention.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: funding to their employing institutions from the National Institute for Health Research (NIHR) Research for Patient Benefit Programme (project reference NIHR204935); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Clinical Trial
Research Registry, 10450
Funding Statement
The study was funded by the United Kingdom National Institute for Health Research (NIHR) Research for Patient Benefit (RfPB) programme (project reference NIHR204935). The funder played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The United Kingdom Health Research Authority and Health and Care Research Wales reference 23/HRA/4572).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
l.j.sutton{at}sheffield.ac.uk
g.fuller{at}sheffield.ac.uk
a.trimble{at}nhs.net
r.pilbery{at}nhs.net
Data Availability
Anonymised data are available from the corresponding author upon reasonable request
